Resources from the same session
Current landscape: Did we learn how to select first-line strategy?
Presenter: Edward Garon
Session: Refining the use of immune-checkpoint inhibition
Resources:
Slides
Webcast
Mechanisms of resistance and novel strategies
Presenter: Céline Mascaux
Session: Refining the use of immune-checkpoint inhibition
Resources:
Abstract
Slides
Webcast
Do we have any idea how to use these drugs in oncogene addicted patients yet?
Presenter: Julien Mazieres
Session: Refining the use of immune-checkpoint inhibition
Resources:
Slides
Webcast